| Medgenics Receives FDA Clearance To Commence Phase IIb Trial Of EPODURE For ... - TheStreet.com (press release) |
|
|
TheStreet.com (press release) Treatment of anemia in dialysis patients with EPODURE is intended to replace frequent injections of EPO or other erythropoietic stimulating agents (“ESAs”). These ETFs hold-up well when the stock market tanks. By Michael Johnston New JCP CEO Ron |